Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEREMIAH E CRABB

Allopathic & Osteopathic Physicians Internal Medicine Critical Care Medicine

NPI
1073509824
CMS profile
1020267
Location
PEORIA, IL

General Payments · PY2018–2023

$1,635.15

  • Reported across 114 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$248.42

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $248.42 16

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $219.86 14
Acerta Pharma LLC $28.56 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $410.04 30
PY2019 $318.29 19
PY2020 $159.97 11
PY2021 $235.61 19
PY2022 $262.82 19
PY2023 $248.42 16

Payment records · PY2023 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $15.01 02/16/2023 Food and Beverage Undisputed 01/23/2026 1011631335 CMS
AstraZeneca Pharmaceuticals LP $13.55 09/14/2023 Food and Beverage Undisputed 01/23/2026 1011440173 CMS
GlaxoSmithKline, LLC. $18.86 01/09/2023 Food and Beverage Undisputed 01/23/2026 1003303463 CMS
GlaxoSmithKline, LLC. $22.87 02/06/2023 Food and Beverage Undisputed 01/23/2026 1003303479 CMS
GlaxoSmithKline, LLC. $11.90 03/09/2023 Food and Beverage Undisputed 01/23/2026 1003304161 CMS
GlaxoSmithKline, LLC. $19.40 03/16/2023 Food and Beverage Undisputed 01/23/2026 1003302791 CMS
GlaxoSmithKline, LLC. $16.70 04/27/2023 Food and Beverage Undisputed 01/23/2026 1003304165 CMS
GlaxoSmithKline, LLC. $16.56 05/25/2023 Food and Beverage Undisputed 01/23/2026 1003302799 CMS
GlaxoSmithKline, LLC. $11.81 06/01/2023 Food and Beverage Undisputed 01/23/2026 1003303471 CMS
GlaxoSmithKline, LLC. $18.90 06/15/2023 Food and Beverage Undisputed 01/23/2026 1003302789 CMS
GlaxoSmithKline, LLC. $9.79 08/17/2023 Food and Beverage Undisputed 01/23/2026 1003304157 CMS
GlaxoSmithKline, LLC. $19.80 10/12/2023 Food and Beverage Undisputed 01/23/2026 1003302769 CMS
GlaxoSmithKline, LLC. $12.39 10/19/2023 Food and Beverage Undisputed 01/23/2026 1003303467 CMS
GlaxoSmithKline, LLC. $14.03 11/16/2023 Food and Beverage Undisputed 01/23/2026 1003302795 CMS
GlaxoSmithKline, LLC. $15.98 12/07/2023 Food and Beverage Undisputed 01/23/2026 1003304153 CMS
GlaxoSmithKline, LLC. $10.87 12/14/2023 Food and Beverage Undisputed 01/23/2026 1003302773 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.